Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO) (HV217026)

Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)
Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)
Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)
Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)
Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)
Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HV217026
説明
Azintuxizumab (HV217026) is a research-grade recombinant antibody targeting CD2. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性Human
アプリケーションELISA, Bioactivity: FACS, Functional assay, Research in vivo
宿主種Human
クローン性Monoclonal
アイソタイプIgG1-kappa
発現システム Mammalian cells
テスト済みアプリケーション WB
ターゲット SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1
エンドトキシンレベル < 10 EU/mg
純度 >95% purity as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 Q9NQ25
形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名ABBV-383, PR-1471272, ABBV-838, 1826819-57-1
背景

SLAM family member 7 (CD319/SLAMF7) is a ~37 kDa protein. Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Isoform 1 mediates NK cell activation through a SH2D1A-independent extracellular signal-regulated ERK-mediated pathway. Positively regulates NK cell functions by a mechanism dependent on phosphorylated SH2D1B.

1. Bouchon, A. et al. (2001) Journal of immunology (Baltimore, Md. : 1950) 167, 5517-21. PMID: 11698418
2. Tassi, I. et al. (2005) Journal of immunology (Baltimore, Md. : 1950) 175, 7996-8002. PMID: 16339536
3. Murphy, JJ. et al. (2002) The Biochemical journal 361, 431-6. PMID: 11802771
4. Kim, JR. et al. (2013) Inflammation research : official journal of the European Histamine Research Society ... [et al.] 62, 765-72. PMID: 23695528
注意事項 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Anti-LASV GPC Recombinant Antibody (Fab 37.7) (VK453013)
イメージ
  • Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)

    Bioactivity

    SEC-HPLC detection for Research Grade Azintuxizumab.

  • Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Azintuxizumab

  • Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)

    Western blot

    Western blot analysis was performed using anti-CD319/SLAMF7 monoclonal antibody at 1μg/ml on various samples.
    Lane 1: recombinant human CD319/SLAMF7 (Catalog No: HV217012), 50ng
    Lane 2: recombinant human CD319/SLAMF7 (Catalog No: HV217012), 30ng

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト